COVID-19 in patients with heart failure: the new and the old epidemic

Nicolò Sisti1, Serafina Valente2, Giulia Elena Mandoli2

  • 1Department of Medical Biotechnologies, Division of Cardiology, University of Siena, Siena, Italy nic.sisti@gmail.com.

Insights

Patients with heart failure face increased risks from severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), causing coronavirus disease 2019 (COVID-19). Special care and therapy adjustments are crucial for managing these high-risk cardiovascular patients.

Area of Science:

  • Infectious Diseases
  • Cardiology
  • Critical Care Medicine

Background:

  • Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) rapidly spread globally, causing the coronavirus disease 2019 (COVID-19) pandemic.
  • Patients with pre-existing cardiovascular diseases, particularly chronic heart failure, exhibit a high prevalence among COVID-19 cases.
  • The combination of COVID-19 and heart failure is associated with a poor prognosis and elevated risk of intensive care unit (ICU) mortality.

Purpose of the Study:

  • To highlight the clinical challenges posed by COVID-19 in patients with heart failure.
  • To underscore the mechanisms by which SARS-CoV-2 impacts myocardial function and exacerbates heart failure.
  • To emphasize the need for specialized care and management strategies for heart failure patients during the COVID-19 pandemic.

Main Methods:

  • This study is a review and clinical perspective based on current literature and clinical observations.
  • Analysis of the interplay between SARS-CoV-2 infection and cardiovascular pathophysiology in heart failure patients.
  • Discussion of potential therapeutic adjustments and monitoring protocols.

Main Results:

  • SARS-CoV-2 infection can precipitate myocardial injury and acute decompensation in patients with chronic heart failure.
  • The viral infection presents unique challenges, potentially worsening cardiac function through various pathophysiological pathways.
  • Effective management requires a re-evaluation of existing medical therapies and vigilant monitoring, especially during ventilatory support.

Conclusions:

  • COVID-19 poses a significant threat to patients with heart failure, increasing morbidity and mortality.
  • A multidisciplinary approach is essential, involving careful assessment of cardiac status and adaptation of treatment plans.
  • Prompt recognition and tailored management are critical for improving outcomes in this vulnerable patient population.

Related Concept Videos

Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
343
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
557
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.5K
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
131
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
593
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
189